Victory Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,034
| Closed | -$208K | – | 2619 |
|
|
2020
Q3 | $208K | Sell |
6,034
-2,064,497
| -100% | -$71.2M | ﹤0.01% | 2275 |
|
|
2020
Q2 | $34.6M | Sell |
2,070,531
-1,703,721
| -45% | -$28.5M | 0.05% | 557 |
|
|
2020
Q1 | $54.4M | Buy |
3,774,252
+1,635,064
| +76% | +$23.6M | 0.05% | 542 |
|
|
2019
Q4 | $71.6M | Buy |
2,139,188
+648,313
| +43% | +$21.7M | 0.09% | 335 |
|
|
2019
Q3 | $31.2M | Buy |
1,490,875
+369,064
| +33% | +$7.73M | 0.04% | 630 |
|
|
2019
Q2 | $23.4M | Buy |
1,121,811
+26,690
| +2% | +$556K | 0.05% | 559 |
|
|
2019
Q1 | $24.5M | Buy |
1,095,121
+145,060
| +15% | +$3.24M | 0.06% | 519 |
|
|
2018
Q4 | $22.7M | Buy |
950,061
+240,310
| +34% | +$5.75M | 0.06% | 508 |
|
|
2018
Q3 | $19.4M | Buy |
709,751
+23,270
| +3% | +$635K | 0.04% | 615 |
|
|
2018
Q2 | $18.5M | Buy |
686,481
+21,840
| +3% | +$587K | 0.04% | 622 |
|
|
2018
Q1 | $21.2M | Buy |
664,641
+600,510
| +936% | +$19.1M | 0.05% | 572 |
|
|
2017
Q4 | $2.43M | Buy |
64,131
+7,830
| +14% | +$296K | 0.01% | 970 |
|
|
2017
Q3 | $1.4M | Buy |
56,301
+8,010
| +17% | +$199K | ﹤0.01% | 1123 |
|
|
2017
Q2 | $993K | Sell |
48,291
-680
| -1% | -$14K | ﹤0.01% | 1187 |
|
|
2017
Q1 | $1.06M | Buy |
+48,971
| New | +$1.06M | ﹤0.01% | 1150 |
|
|
2016
Q4 | – | Sell |
-38,570
| Closed | -$579K | – | 1845 |
|
|
2016
Q3 | $579K | Buy |
+38,570
| New | +$579K | ﹤0.01% | 1215 |
|